IsoRay (NYSE:ISR) is facing putative class-action lawsuits from shareholders accusing the company of making false or misleading statements about a clinical trial of its Cesium 131 brachytherapy seeds designed to treat cancer. The lawsuits, from at least 3 different shareholders, claim that IsoRay made false statements about a clinical study of Cesium 131. The study was the 1st […]
March 24, 2014 by Brad Perriello
Kauffman had been with the company since 2005 and was named vice-chairman in 2008. IsoRay is looking to fill the hole he left behind, but there are no immediate nominations or arrangements, according to an IsoRay regulatory filing.
MASSDEVICE ON CALL — Rep. Erik Paulsen’s long-running effort to repeal the medical device excise tax is nearing a climax in the House, the Congressman said during a recent episode of his regular "Correspondence Corner" videos.
Before answering questions sent by his constituents, Paulsen gave a shout out to Minnesota medical device makers and said he expects his tax repeal bill to get a House vote this week.
Masimo (NSDQ:MASI) met Wall Street’s forecast for its full-year and 4th-quarter earnings, giving its shares a 2% bump yesterday and sending them another 3% higher today.
The Irvine, Calif.-based patient monitoring systems maker reported profits of $$13.8 million, or 23 cents per share, on sales of $112.3 million for the 3 months ended Dec. 31, 2011, for a top-line increase of 6.4% but a bottom-line decline of 14.2%, compared with Q4 2010.
The U.S. Supreme Court heard oral arguments this week in a case that could have wide-reaching implications for health care: Whether medical patents should be allowed.
At issue is the specter of doctors being sued for patent infringement based on treatment decisions derived from the scientific research underpinning the patent.
Medtronic Inc. (NYSE:MDT) won FDA clearance for its next generation iPro2 Professional continuous glucose monitor.
The iPro2 Professional is a clinician-owned device that collects glucose data from a sensor inserted into a patient’s skin.
The device tracks the patient’s glucose levels for 3 days, collecting data as many as 288 times each day. The information may provide insight into how diet, medication and daily activities affect a patient’s glucose levels.